Form 4: HCA Healthcare Executive Sells Shares After PSU Vesting

HCA Healthcare's SVP & Chief Human Resources Officer, Jennifer Berres, reported the vesting of performance share units and subsequent sales of common stock.

Summary

• Jennifer Berres, SVP & Chief Human Resources Officer of HCA Healthcare, Inc., reported transactions involving the company's common stock.
• On February 10, 2026, 7,116 performance share units (PSUs) vested, increasing her beneficial ownership to 22,528 shares.
• These PSUs were granted on January 30, 2023, and vested at 200% of the granted units (3,558 units) due to HCA Healthcare achieving 110% or more of its cumulative earnings per share goal for fiscal years 2023-2025.
• Also on February 10, 2026, 2,515 shares were disposed of at a price of $502.05, likely for tax withholding purposes, reducing beneficial ownership to 20,013 shares.
• On February 11, 2026, 4,010 shares were sold at $503 per share, leaving 16,003 shares.
• Later on February 11, 2026, an additional 4,010 shares were sold at a weighted average price of $526.1646, with individual transaction prices ranging from $525.97 to $526.3101, resulting in a final beneficial ownership of 11,993 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as the 200% vesting of performance share units reflects strong company performance against its earnings per share targets, despite the subsequent insider sales.

Positives

• The performance share units vested at 200% of the granted amount, indicating HCA Healthcare achieved 110% or more of its cumulative earnings per share goal for fiscal years 2023-2025, reflecting strong company performance.

Negatives

• The executive sold a significant portion of the vested shares, which, while common for managing equity compensation, represents a reduction in insider holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance metrics like EPS is a common practice in the healthcare industry, aligning management incentives with shareholder value. The successful vesting at maximum levels suggests HCA Healthcare's strong operational execution within its sector.

Comparison to Industry Standards

• Executive compensation structures, particularly those involving performance-based equity awards like PSUs, are standard across large-cap healthcare providers such as UnitedHealth Group (UNH) or Anthem (ANTM).
• The 200% vesting indicates HCA Healthcare's strong performance relative to its internal targets, which is a positive signal for its operational efficiency and financial health compared to peers.

Stakeholder Impact

• Shareholders benefit from the strong company performance indicated by the maximum vesting of performance share units, which suggests effective management and achievement of financial goals.

Key Dates

Recommendation

The filing indicates strong company performance leading to maximum vesting of executive performance shares. While there are subsequent sales, these are typical for executives managing their equity compensation and do not necessarily signal a negative outlook on the company. The underlying performance is positive, suggesting a 'hold' for existing investors.

Keywords

HCA Healthcare, HCA, Form 4, Insider Trading, Stock Sale, Performance Share Units, Executive Compensation, Jennifer Berres